SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Akanda Corp. is a cannabis cultivation, manufacturing, and distribution company, which engages in the provision of premium quality and ethically sourced medical cannabis products to patients. The company cultivates and processes natural cannabis at facilities in the Kingdom of Lesotho, Africa and intend to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers. It also imports and sells medical cannabis-based products. The company was founded on July 16, 2021 and is headquartered in New Romney, the United Kingdom.

Akanda Corp

Akanda Corp is experiencing a parabolic rally driven by a low-float setup and intense short-squeeze dynamics that have captured the attention of retail traders. The community is actively debating the stock's long-term sustainability against its history of reverse splits and high borrowing costs, while many speculate about the potential for further explosive gains.

NIO, Inc. operates as a holding company, which engages in the design, development, manufacture, and sale of smart electric vehicles. It offers its products under the brands NIO, ONVO, and FIREFLY. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Shanghai, China.

NIO Inc - ADR

NIO Inc

NIO is trending as investors weigh strong April year-over-year delivery growth and the launch of the Onvo L80 against ongoing delivery logistics debates and broader market volatility. Community discourse remains deeply divided between long-term holders citing the company's battery-swapping infrastructure as a massive competitive advantage and skeptics pointing to concerns over share dilution, debt, and persistent bearish price action.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk (SNDK) is experiencing a high-volatility "sell the news" reaction despite delivering a record-breaking earnings beat and issuing bullish guidance that underscores sustained AI-driven demand. While the community is debating whether this dip offers a strategic buying opportunity or confirms a long-overdue valuation cooling after a historic year-long rally, many investors are focused on the company's aggressive share buyback plan as a potential defensive catalyst.

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of immunotherapies to treat cancer and autoimmune diseases. Its products include CUE-400 series (autoimmune diseases), CUE-500 series (targeted cell depletion), and CUE-100 series (Oncology). The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Cue Biopharma Inc

Cue Biopharma is trending due to the announcement of a multi-million dollar milestone payment from its partnership with Boehringer Ingelheim, which has triggered heightened trader interest ahead of an R&D Day presentation. Community sentiment is mixed, with some traders optimistic about the non-dilutive capital and autoimmune pipeline potential, while others remain cautious due to concerns over potential share dilution and a pending reverse stock split.

Roblox Corp. engages in the provision of online gaming services. Its platform consists of Roblox Client, Roblox Studio, and Roblox Cloud. Roblox Client is an application that allows users to explore 3D digital worlds. Roblox Studio is the toolset that allows developers and creators to build, publish, and operate 3D experiences and other content accessed with Roblox Client. Roblox Cloud includes the services and infrastructure that power the human co-experience platforms. The company was founded by Erik Cassel and David B. Baszucki in March 2004 and is headquartered in San Mateo, CA.

Roblox Corporation - Ordinary Shares - Class A

Roblox Corp.

Roblox is facing significant downward pressure as investors react to a lowered bookings guidance and user engagement headwinds caused by the platform's recent safety and age-check rollout. The community remains deeply polarized, with bears focusing on the company's lack of profitability and safety concerns, while bulls point to strong free cash flow and long-term potential in the creator economy.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian shares are surging after delivering a strong quarterly earnings beat, fueling investor optimism that the enterprise software sector may be bottoming out. The community is actively debating if this performance signals a broader recovery for SaaS companies or if it remains a tactical bounce amid ongoing concerns over AI-driven disruption.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart is seeing heightened community discussion as investors weigh the impact of new capital partnerships against broader sector volatility and bearish sentiment surrounding fintech. While some market participants anticipate a potential short squeeze, others remain cautious as the stock grapples with macroeconomic headwinds and lingering uncertainty regarding the company's performance in a high-rate environment.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

Investors are closely monitoring escalating geopolitical tensions in the Strait of Hormuz and a shifting conflict status with Iran, which is driving significant volatility and concerns over energy supply stability. The community is actively debating whether current stock market highs are sustainable in the face of these rising oil prices, Fed policy uncertainty, and mixed earnings reports.

iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Woburn, MA.

iSpecimen Inc

iSpecimen Inc. is attracting significant community attention due to its status as a low-float stock experiencing intense volatility, with retail investors closely monitoring for a potential short squeeze amid rumors of strategic acquisitions. Community sentiment is deeply polarized, with active debates centered on the company's long-term viability, upcoming delisting concerns, and the high-conviction participation of retail traders hoping to replicate past momentum spikes.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. is trending as traders closely monitor its role as a leveraged Bitcoin proxy, with community discussion currently polarized between optimism over institutional accumulation and concerns regarding structural dilution. Investors remain focused on how the company's treasury strategy and dividend structure will perform in relation to broader Bitcoin price volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What's Going On With Shares Of SeaStar Medical Today?

Shares of SeaStar Medical Holding Corporation (NASDAQ: ICU) are trading lower Friday after the company initiated a reverse stock split.read more...

A Glimpse of SeaStar Medical Holding's Earnings Potential

SeaStar Medical Holding Corp. shares rose 7% to their highest level in more than three months on Wednesday after the company said an independent safety board had reviewed early data and recommended continuing its pivotal trial of a kidney failure therapy.However, the stock&nbsp;crashed 46% in after-hours trading on Wednesday.The Data Safety Monitoring Board (DSMB) conducted an interim review of the first 100 patients in the Neutralize-AKI study of the company’s Selective Cytopheretic Device (SCD) in adults with acute kidney injury requiring continuous renal replacement therapy.&nbsp;The panel found no device-related safety concerns and reported zero adverse events tied to the treatment. It also flagged a signal of potential clinical benefit across key measures.To boost the statistical power of the trial, the DSMB recommended increasing enrollment from 200 to 339 patients. SeaStar said 137 patients have already been enrolled and expects to complete recruitment near the end of 2026. The company plans to accelerate enrollment by adding new trial sites.The Neutralize-AKI trial will measure a composite of 90-day mortality or dialysis dependency, with additional endpoints including 28-day mortality, ICU-free days, and dialysis dependency at one year. Subgroup analyses will evaluate patients with sepsis and acute respiratory distress syndrome.SeaStar’s SCD therapy, marketed as Quelimmune, is already approved by the FDA for life-threatening acute kidney injury in children with sepsis or septic conditions. Early real-world registry data showed no safety concerns and a 75% survival rate at 28 days, suggesting a possible reduction in mortality compared with historical outcomes.On Stocktwits, retail sentiment was ‘extremely bullish’ amid ‘extremely high’ message volume.One user suggested that warrant holders had timed the news to capitalize on the stock’s spike, noting they could profit as long as shares remained above their average price and questioning whether the market could absorb the additional supply.<stembedurl>https://stocktwits.com/alphaonetrading/message/629922155</stembedurl>Another user said the recent price surge was only the beginning, arguing that strong safety signals from the trial support future runs and calling any near-term pullback a buying opportunity for the long term.<stembedurl>https://stocktwits.com/MasheredTrader/message/629918153</stembedurl><a href="https://stocktwits.com/symbol/ICU">SeaStar Medical’s stock</a> has declined 36.1% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Chronic kidney disease, computer illustration and light micrograph. The illustration shows the gross anatomy of kidneys with chronic glomerulonephritis. | Image source: Getty Images

SeaStar Medical Stock Jumps On Safety Board Backing For Kidney Trial; Retail Eyes Another Run Despite After-Hours Plunge

SeaStar’s SCD therapy, marketed as Quelimmune, is already approved by the FDA for life-threatening acute kidney injury in children with sepsis or septic conditions.

Equity

The trial’s enrollment target has been raised to 339 patients, with completion expected by late 2026.

Shares of SeaStar Medical Holding Corporation (ICU) slumped 61% on Friday afternoon after the healthcare company <a target="_blank" rel="noopener noreferrer nofollow" href="https://investors.seastarmedical.com/news/news-details/2025/SeaStar-Medical-Announces-Pricing-of-Up-to-8-Million-Public-Offering/default.aspx">announced</a> the pricing of a public offering of over six million shares of its common stock at $0.65.The offer price of $0.65 represents a 33% discount on the stock’s closing price on Wednesday.The gross proceeds to the company from the offering are expected to be approximately $4 million, before deducting the placement agent’s fees and other offering expenses payable. SeaStar said it intends to use the net proceeds from the offering for general corporate purposes. The offering is expected to close on or about June 23, 2025.SeaStar Medical is a commercial-stage healthcare company focused on treatments for critically ill patients facing organ failure and potential loss of life.Its Quelimmune product was approved by the U.S. Food and Drug Administration (FDA) last year for the ultra-rare condition of life-threatening acute kidney injury (AKI) due to sepsis or a septic condition in critically ill pediatric patients.On Stocktwits, retail sentiment around SeaStar rose from ‘neutral’ to ‘bullish’ over the past 24 hours while message volume remained ‘high’.<figure class="image"><img style="aspect-ratio:622/64;" src="https://news.stocktwits-cdn.com/Screenshot_2025_06_20_at_1_11_54_PM_png_87eaa0be26.webp" alt="ICU's Sentiment Meter and Message Volume as of 1:10 p.m. ET on June 20, 2025 | Source: Stocktwits" width="622" height="64"><figcaption>ICU's Sentiment Meter and Message Volume as of 1:10 p.m. ET on June 20, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed dissatisfaction with the lack of clarity around the management’s decisions.<stembedurl>https://stocktwits.com/Saxon_stock/message/618487152</stembedurl>Another opined that the company is inching close to bankruptcy.<stembedurl>https://stocktwits.com/Cowsheeptheone/message/618483251</stembedurl><a href="https://stocktwits.com/symbol/ICU">ICU stock</a> is down by 81% this year and by over 93% in the past 12 months.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/amazon-ends-kia-soul-same-day-delivery-program/chlxYXvRRPx">Amazon Ends Same-Day Deliveries Via Kia Souls, Leans On Its Network Of Gig Workers: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

SeaStar Medical Stock Tanks At Discounted Pricing Of Public Offering, Retail Believes Company Is Inching Closer To Bankruptcy

The public offer price of $0.65 represents a 33% discount on the stock’s closing price on Wednesday.

Seastar Medical Holding Corp. operates as a holding company whose subsidiaries manufacture and supply medical devices. The company was founded on June 6, 2007 and is headquartered in Denver, CO.

ICU
SeaStar Medical Holding Corp

Feed

News

Sentiment

Fundamentals

Info

Latest ICU News

ICUSeaStar Medical Holding Corp